Skip to main content
Premium Trial:

Request an Annual Quote

FYR Diagnostics Wins $618K NIH Grant to Develop Acquired Epilepsy Assay

NEW YORK — FYR Diagnostics said today that it has been awarded a National Institutes of Health grant worth up to $618,086 to develop a microRNA-based assay for the detection of acquired epilepsy.

Acquired epilepsy is a form of the neurological disorder that results from other conditions such as stroke, infections, and traumatic brain injury. 

With the two-year Phase I Small Business Innovation Research grant, FYR will perform studies in animal models to determine whether plasma miRNAs can serve as biomarkers of acquired epilepsy caused by brain injury — known as post-traumatic epilepsy — using an assay based on a proprietary isothermal chemistry called ultrasensitive DNA amplification reaction, or UDAR. 

FYR President Sarj Patel said in a statement that the Missoula, Montana-based firm intends to ultimately commercialize the assay.

The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.